Overcoming Drug Resistance: The EGFR Enigma, Part 2
This post explores the challenges we face with anti-EGFR monoclonal antibody therapies and new strategies researchers have developed to...
Category: Research
This post explores the challenges we face with anti-EGFR monoclonal antibody therapies and new strategies researchers have developed to...
Currently, anti-EGFR therapies are approved by the U.S. Food and Drug Administration for the treatment of non-small cell lung...
This year, at the AACR Annual Meeting held in Philadelphia April 18 to 22, an astounding 19,300 members of...
In my first post in this series highlighting some of the studies presented at the AACR Annual Meeting 2015...
Tamas A. Gonda, MD, 2014 recipient of the Landon Foundation-AACR INNOVATOR Award for Cancer Prevention Research, is examining how...
Game-changing modern cancer therapies—immunotherapies and targeted therapies, among others—have been providing promising treatment outcomes in the recent years. The...
Immunotherapeutics called PD-1 inhibitors have garnered a lot of attention in the past year thanks to exciting clinical trial...
As Kidney Cancer Awareness Month draws to a close, Scott M. Welford, PhD, the 2014 recipient of the Kure...
Guest Post by Toni Kay Mangskau Mayo Clinic Cancer Center
There has been a series of immunotherapy approvals since the end of last year, and following this trend, on...